Clean Cheap Nat Gas-Who Cares? Supply and Demand is Predictable
Update 2/25/11 T.Boone Pickens Cares With oil in the $100 range Nat Gas is getting more attention. That goes along with the usual talk about our lack of energy policy and the U.S. addiction to oil.T.Boone Pickens was on CNBC today and when asked what to do about “ol” said two...
NASDAQ down 1.2% to 2723 But Biotech Has Two Big Winners:Exelixis(EXEL) and Vertex(VRTX),
Biotech ETF’s and Major Indices are 5% off mid-January highs NADAQ stocks sold off for a second day but biotechnology stocks were mixed with a few winners.Major biotech ETF’s were down about 0.75% and off 5% from their 2011 highs in mid-January, the seasonal top in the biotech...
Good Time to look at Optimer (OPTR $12.00) Pharmaceuticals
On Feb.11 Optimer completed a 6M share offering of common stock at a price of $11.25 sh. and the stock has held up well despite the dilution. On February 7 the Company announced a deal with Astellas Pharmaceutical licensing off rights to their Fidaxomycin C.diff drug for Europe, parts of...
Biotech Stocks Get A Boost from the BIO CEO Conference:Exelixis(EXEL)and Optimer(OPTR)
BIO CEO and Investor Conference Feb 14-15 Biotechnology stocks picked up some buying interest today from the BIO CEO Conference in NYC. CNBC provided some CEO clips from Exelixis (EXEL $10.58) up 7%, Onyxx(ONXX $36.28) up 0.28% and Optimer (OPTR $11.61) up 2.83%. Onyyx is a cancer drug...
Biotechnology Portfolio Notes:CEPH,IVD,SRLS
Techs (QLD up 1.23%) outperformed biotechs today as Cisco bad news was forgotten. Biotech stocks treaded water today as all major ETF’s were flat. On the news front: Cephalon(CEPH $58.20) was down 3.17% on heavy volume as investors sold on there earnings report and an FDA subpoena about...
